Novavax | NVAX - Loan Capital

Stock Price
8.45
Daily Change
-0.50 -5.59%
Monthly
-16.42%
Yearly
20.71%
Q1 Forecast
8.20

Novavax reported $246.3M in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Adma Biologics USD 69.33M 750K Dec/2025
Agenus USD 169.66M 146.06M Dec/2025
AstraZeneca USD 26.14B 19.58B Dec/2025
BioCryst Pharmaceuticals USD 428.67M 234.31M Dec/2025
Cassava Sciences USD 0 0 Dec/2024
Geron USD 119.55M 283K Dec/2025
GlaxoSmithKline GBP 14.71B 186M Dec/2025
MannKind USD 548.44M 244.79M Dec/2025
Merck USD 39.97B 6B Sep/2025
Minerva Neurosciences USD 0 86.58M Sep/2024
Moderna USD 610M 584M Dec/2025
Novartis USD 29.59B 5.35B Dec/2025
Novavax USD 246.3M 200K Dec/2025
Pfizer USD 57.41B 93M Sep/2025
Sanofi EUR 15.72B 2.45B Dec/2025
Sarepta Therapeutics USD 828.97M 206.17M Dec/2025
TG Therapeutics USD 245.64M 305K Dec/2025